Published in Lancet on April 16, 1988
Furocyst - Poly Cystic Ovary Syndrome Study | NCT02703064
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid | NCT01487486
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ (2003) 2.40
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci U S A (1995) 1.64
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol (2014) 1.41
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest (1995) 1.32
The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab (2010) 1.27
Polycystic ovarian syndrome: diagnosis and management. Clin Med Res (2004) 1.24
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2014) 1.15
Quality of life of hirsute women. Postgrad Med J (1993) 1.12
Recurrent early miscarriage and polycystic ovaries. BMJ (1988) 1.11
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab (2009) 1.03
Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab (2010) 1.01
Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ (1988) 1.01
Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab (2009) 0.99
Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet (1997) 0.99
Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am (2005) 0.93
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril (2010) 0.92
Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Hum Reprod (2009) 0.90
Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries. Reprod Biol Endocrinol (2008) 0.89
Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry (2002) 0.87
Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am (2011) 0.85
Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome. Clin Exp Reprod Med (2014) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Brachial artery conductance during reactive hyperemia is increased in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2010) 0.83
Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease. Epilepsy Curr (2005) 0.82
Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging. Eur Radiol (2009) 0.82
Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health (2010) 0.81
Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries. Reproduction (2008) 0.81
Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications. Onco Targets Ther (2014) 0.80
The pathogenetic enigma of polycystic ovary syndrome. J Ultrasound (2007) 0.78
Ultrasonography shows no abnormality of pelvic structures in women with severe idiopathic constipation. Gut (1989) 0.78
Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'. J R Soc Med (1995) 0.78
Polycystic ovary syndrome in university students: occurrence and associated factors. Int J Fertil Steril (2014) 0.77
Insulin resistance and fertility in polycystic ovary syndrome. J Med Life (2010) 0.77
Current trends in the treatment of polycystic ovary syndrome with desire for children. Ther Clin Risk Manag (2009) 0.77
Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet (2013) 0.77
Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility. PLoS One (2013) 0.76
Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol (2005) 0.76
Cystic ovaries in women affected with hereditary angioedema. Clin Exp Immunol (1992) 0.76
Women and epilepsy. J Pediatr Pharmacol Ther (2009) 0.75
Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT. Int J Reprod Biomed (Yazd) (2016) 0.75
Prevalence of polycystic ovaries in women with acne. Arch Dermatol Res (1989) 0.75
Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis. PLoS One (2016) 0.75
Polycystic ovary syndrome in patients on antiepileptic drugs. Ann Indian Acad Neurol (2016) 0.75
Amygdala Kindling Alters Estrus Cycle and Ovarian Morphology in the Rat. Int J Sci (2013) 0.75
The treatment of patients with polycystic ovaries undergoing IVF. J Assist Reprod Genet (1997) 0.75
Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome. Int J Fertil Steril (2015) 0.75
Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome. Endocrinology (2016) 0.75
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
Sexual lifestyles and HIV risk. Nature (1992) 8.24
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet (1984) 6.63
Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord (2001) 5.97
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Estimation of the number of sex alleles and queen matings from diploid male frequencies in a population of Apis mellifera. Genetics (1977) 3.98
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg (1997) 3.57
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
Evolution of Escherichia coli during growth in a constant environment. Genetics (1987) 3.44
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Potent selective inhibitors of protein kinase C. FEBS Lett (1989) 3.24
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Sexual lifestyles under scrutiny. Nature (1990) 3.19
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Coronary vasospasm induced by subcutaneous sumatriptan. BMJ (1992) 3.13
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Who goes to sexually transmitted disease clinics? Results from a national population survey. Genitourin Med (1996) 3.02
Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ (1995) 2.96
Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) (1978) 2.91
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun (1990) 2.77
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65
Family type and accidents in preschool children. J Epidemiol Community Health (1983) 2.61
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry (1991) 2.57
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med (2000) 2.49
Admixture studies and the detection of selection. Science (1973) 2.41
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev (2007) 2.26
Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
A pilot study of sexual lifestyle in a random sample of the population of Great Britain. AIDS (1989) 2.13
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group. Osteoporos Int (1991) 2.07
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol (1978) 2.07
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Teenage mothering, admission to hospital, and accidents during the first 5 years. Arch Dis Child (1983) 2.04
Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut (1991) 2.04
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Breast-feeding, bronchitis, and admissions for lower-respiratory illness and gastroenteritis during the first five years. Lancet (1982) 2.03
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99
Estimation of phylogenetic relationships from DNA restriction patterns and selection of endonuclease cleavage sites. Proc Natl Acad Sci U S A (1982) 1.98
Methodology of the National Survey of Sexual Attitudes and Lifestyles. J R Stat Soc Ser A Stat Soc (1993) 1.95
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet (1997) 1.91
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
Maternal smoking during pregnancy and lower respiratory tract illness in early life. Arch Dis Child (1987) 1.89
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J (2000) 1.87
Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol (1978) 1.86
Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci (1982) 1.85
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Breast feeding, eczema, asthma, and hayfever. J Epidemiol Community Health (1983) 1.80
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab (2009) 1.77
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med (1986) 1.77
Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Pertussis immunisation and serious acute neurological illnesses in children. BMJ (1993) 1.71
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Measles vaccination and neurological events. Lancet (1997) 1.66
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol (1977) 1.65
Total excision or restorative resection for carcinoma of the middle third of the rectum. Br J Surg (1979) 1.63
Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63
Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1988) 1.62
Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) (1975) 1.61
Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet (1994) 1.58
Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod (1993) 1.58
Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc (1995) 1.58
Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf) (1992) 1.57
An evaluation of 'rapid review' as a method of quality control of cervical smears using the AxioHOME microscope. Cytopathology (1997) 1.56
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr (1991) 1.53
Breast feeding and child development at five years. Dev Med Child Neurol (1984) 1.52
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Assessing participation bias in a sexual behaviour survey: implications for measuring HIV risk. AIDS (1997) 1.49
Private sexual behavior, public opinion, and public health policy related to sexually transmitted diseases: a US-British comparison. Am J Public Health (1998) 1.49
Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol (2002) 1.49
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ (1991) 1.48